Murray A. Goldberg - 19 Jan 2023 Form 3 Insider Report for Ayala Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Murray A. Goldberg
Issuer symbol
N/A
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
23 Jan 2023, 17:15:38 UTC
Previous filing
15 Jun 2022

No securities are beneficially owned.